Wei Peu Zen - 15 Dec 2023 Form 4 Insider Report for Emmaus Life Sciences, Inc. (EMMA)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
19 Dec 2023, 19:40:45 UTC
Prior SEC filing
20 Jan 2023
Next SEC filing
05 Feb 2024
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
Wei Peu Zen

Key filing fact

Wei Peu Zen filed Form 4 for Emmaus Life Sciences, Inc. (EMMA) on 19 Dec 2023.

Key facts

  • This page summarizes Wei Peu Zen's Form 4 filing for Emmaus Life Sciences, Inc. (EMMA).
  • 2 reported transactions and 1 derivative row are listed below.
  • Accepted by SEC: 19 Dec 2023, 19:40.

Change

  • Previous filing in this sequence was filed on 20 Jan 2023.
  • Current net transaction value: +$90,685.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

EMMA transaction

Common stock, $0.001 par value

Other

Transaction value
$1,090,685
Shares
+3,760,983
Change %
+373%
Price
$0.2900
Shares after
4,768,817
Date
15 Dec 2023
Ownership
Direct
Footnotes
F1
EMMA holding

Common stock, $0.001 par value

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
1,270,214
Date
15 Dec 2023
Ownership
By Profit Preview International Group Limited
Footnotes
F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

EMMA transaction Derivative

Convertible Promissory Note dated 2023-01-18

Other

Transaction value
$1,000,000
Shares
-2,000,000
Change %
-100%
Price
$0.5000
Shares after
0
Date
18 Jan 2023
Ownership
Direct
Underlying class
Common Stock
Underlying amount
2,000,000
Exercise price
$0.5000
Footnotes
F3, F4
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 4 footnotes

Footnote F1

The shares shown were issued in exchange for principal and accrued interest under the promissory note of the Issuer held by the reporting person referred to in footnote (2), below, which promissory note was surrendered by the reporting person for cancellation.

Footnote F2

Profit Preview International Group Limited is a Hong Kong limited company wholly owned by the Reporting Person and of which the Reporting Person is a director.

Footnote F3

The Convertible Promissory Note dated 2023-01-18 was surrendered to the Issuer for cancellation in exchange for the shares referred to in footnote (1), above.

Footnote F4

Represent shares previously issuable upon conversion of the Convertible Promissory Note.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .